Cargando…

PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION

Detalles Bibliográficos
Autores principales: Sofía, Álvarez-Galeano, Salazar-Hidalgo, Milton, Benavente, Celina, López-Lorenzo, José Luis, Anguita, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430243/
http://dx.doi.org/10.1097/01.HS9.0000974116.36901.ed
_version_ 1785090914700492800
author Sofía, Álvarez-Galeano
Salazar-Hidalgo, Milton
Benavente, Celina
López-Lorenzo, José Luis
Anguita, Eduardo
author_facet Sofía, Álvarez-Galeano
Salazar-Hidalgo, Milton
Benavente, Celina
López-Lorenzo, José Luis
Anguita, Eduardo
author_sort Sofía, Álvarez-Galeano
collection PubMed
description
format Online
Article
Text
id pubmed-10430243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104302432023-08-17 PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION Sofía, Álvarez-Galeano Salazar-Hidalgo, Milton Benavente, Celina López-Lorenzo, José Luis Anguita, Eduardo Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430243/ http://dx.doi.org/10.1097/01.HS9.0000974116.36901.ed Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Sofía, Álvarez-Galeano
Salazar-Hidalgo, Milton
Benavente, Celina
López-Lorenzo, José Luis
Anguita, Eduardo
PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
title PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
title_full PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
title_fullStr PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
title_full_unstemmed PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
title_short PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
title_sort pb1817: the addition of zalcitabine to acute myeloid leukemia treatment may improve azacitidine and venetoclax combination
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430243/
http://dx.doi.org/10.1097/01.HS9.0000974116.36901.ed
work_keys_str_mv AT sofiaalvarezgaleano pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination
AT salazarhidalgomilton pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination
AT benaventecelina pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination
AT lopezlorenzojoseluis pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination
AT anguitaeduardo pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination